Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Cancer CARE (Connected Access and Remote Expertise) Beyond Walls - Safety, Feasibility, and Patient Experience of Home-Based Chemotherapy.
Journal: NEJM catalyst innovations in care delivery
Published: July 08, 2026
Study of the Perceptions and Concerns of a Single Health System Hematology and Oncology Workforce About Artificial Intelligence in Clinical Practice and Medical Education.
Journal: JCO clinical cancer informatics
Published: March 30, 2026
Concordance of Circulating Tumor DNA, Primary and Metastatic Tissue DNA, and Immunohistochemistry in Gastroesophageal Carcinoma.
Journal: JCO precision oncology
Published: March 25, 2026
Multikinase inhibitors in refractory metastatic colorectal cancer: an optimal sequence?
Journal: Clinical advances in hematology & oncology : H&O
Published: February 20, 2026
Switch from cetuximab to panitumumab during encorafenib-based therapy in BRAF V600E mutated metastatic colorectal cancer: An international multicenter analysis from the AGEO group.
Journal: Clinics and research in hepatology and gastroenterology
Published: September 16, 2025
Circulating Tumor DNA and Tissue Testing for Pancreatobiliary Tumors.
Journal: JAMA network open
Published: September 12, 2025
Is there a place for deceased donor liver transplantation for colorectal metastases in the United States? Feasibility of a protocol utilizing machine perfusion.
Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Published: June 30, 2025
Successful Management of BRAF V600E-Mutated Metastatic Colorectal Cancer With Liver Dysfunction Using Encorafenib-Based Therapy.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: June 11, 2025
Evaluating Food and Drug Administration approved gastrointestinal cancer drugs: clinical benefit and trial endpoints over the past two decades.
Journal: The oncologist
Published: May 16, 2025
Tucatinib in the treatment of HER2-overexpressing gastrointestinal cancers: current insights and future prospects.
Journal: Expert opinion on investigational drugs
Published: February 28, 2025
Last Updated: 09/26/2026